Skip to content
Catalyst

steviosideWhat was measured

Measured, with no finding

16 endpoints

Show what was measuredHide what was measured
  • Direct-acting mutagenicity of steviol-16 alpha,17-epoxide

    no effect

    A potential metabolite of steviol, steviol-16 alpha,17-epoxide, was synthesized chemically and found to be ineffective as a direct-acting mutagen.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of dihydrosteviol A and B

    no effect

    Similarly, chemical reduction of the unsaturated bond linking the carbon-16 and -17 positions of steviol resulted in the generation of two isomeric products, dihydrosteviol A and B, that were not mutagenic.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of ent-kaurenoic acid

    no effect

    In addition, ent-kaurenoic acid was found to be inactive.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of isosteviol

    no effect

    The structurally related species, isosteviol, was not active regardless of metabolic activation.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of steviol in S. typhimurium TM677 with rat liver S9

    increases

    However, steviol, the aglycone of stevioside, was found to be highly mutagenic when evaluated in the presence of a 9000 X g supernatant fraction derived from the livers of Aroclor 1254-pretreated rats.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of stevioside in S. typhimurium TM677

    no effect

    Consistent with reports in the literature, we have found that stevioside is not mutagenic as judged by utilization of Salmonella typhimurium strain TM677, either in the presence or in the absence of a metabolic activating system.

    PMID 3887402 · one of two readings recorded this

  • mutagenicity of stevioside in Salmonella typhimurium strain TM677, with and without metabolic activation (9000 x g rat liver supernatant)

    no effect

    Not recorded as a finding: this platform holds no node for the endpoint

    Consistent with reports in the literature, we have found that stevioside is not mutagenic as judged by utilization of Salmonella typhimurium strain TM677, either in the presence or in the absence of a metabolic activating system.

    PMID 3887402 · one of two readings recorded this

  • mutagenicity of stevioside in the Salmonella typhimurium strain TM677 forward-mutation assay, with and without metabolic activation (Aroclor 1254-induced rat liver S9 plus NADPH)

    no effect

    Not recorded as a finding: this platform holds no node for the endpoint

    Consistent with reports in the literature, we have found that stevioside is not mutagenic as judged by utilization of Salmonella typhimurium strain TM677, either in the presence or in the absence of a metabolic activating system.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of structurally related sweet-tasting glycosides

    no effect

    Similar negative results were obtained with several structurally related sweet-tasting glycosides.

    PMID 3887402 · one of two readings recorded this

  • Mutagenicity of unmetabolized steviol (dependence on rat pretreatment and NADPH)

    no effect

    Expression of mutagenic activity was dependent on both pretreatment of the rats with Aroclor 1254 and addition of NADPH; unmetabolized steviol was not active

    PMID 3887402 · one of two readings recorded this

  • incidence and extent of papillary or nodular (PN) hyperplasia of the urinary bladder, histological examination, in BBN-initiated male F344 rats fed 5% stevioside for 32 weeks

    no effect

    Not recorded as a finding: this platform holds no node for the endpoint

    Administration of 5% aspartame or 5% stevioside in the diet did not, however, affect the incidence or extent of PN hyperplasia in BBN-treated rats.

    PMID 6500232 · one of two readings recorded this

  • incidence and extent of papillary or nodular (PN) hyperplasia of the urinary bladder, histology, in BBN-initiated male F344 rats fed 5% stevioside

    no effect

    Not recorded as a finding: this platform holds no node for the endpoint

    Administration of 5% aspartame or 5% stevioside in the diet did not, however, affect the incidence or extent of PN hyperplasia in BBN-treated rats.

    PMID 6500232 · one of two readings recorded this

  • Incidence and extent of papillary or nodular (PN) hyperplasia of the urinary bladder in BBN-treated rats

    no effect

    Administration of 5% aspartame or 5% stevioside in the diet did not, however, affect the incidence or extent of PN hyperplasia in BBN-treated rats

    PMID 6500232 · one of two readings recorded this

  • Incidence and extent of papillary or nodular (PN) hyperplasia of the urinary bladder in BBN-treated rats

    increases

    Treatment with sodium saccharin significantly increased the incidence and extent of preneoplastic lesions, papillary or nodular (PN) hyperplasia, in rats treated with BBN for 4 weeks

    PMID 6500232 · one of two readings recorded this

  • Incidence and extent of papillary or nodular (PN) hyperplasia of the urinary bladder in BBN-treated rats

    no effect

    Administration of 5% aspartame or 5% stevioside in the diet did not, however, affect the incidence or extent of PN hyperplasia in BBN-treated rats

    PMID 6500232 · one of two readings recorded this

  • Preneoplastic or neoplastic urinary bladder lesions in rats treated with test sweeteners only

    no effect

    No preneoplastic or neoplastic lesions of the urinary bladder were observed in rats treated with the test sweeteners only

    PMID 6500232 · one of two readings recorded this